BAYLOR COLLEGE OF MEDICINE will collaborate with Biocept Inc. to develop minimally invasive blood-based tests using Biocept’s circulating tumor cell and circulating tumor DNA molecular diagnostic assay platforms to detect mutations in the estrogen receptor gene ESR1.
Over the course of his first six months as NCI director, Anthony Letai has contended with federal budget turbulence, a record-setting government shutdown, and concerns about the flow of over research dollars.
